Cashu
Cidara Therapeutics: Innovating Antifungal Treatments to Combat Resistance and Improve Outcomes
6 days ago
Stocks
Health Care
cdtx
Cidara Therapeutics
NASDAQ: CDTX
+111.68 (+105.37%)
217.67
USD
At close at Nov 14, 21:39 UTC
Overview
Loading chart...
Key Stats
Market Cap
2.69B
Dividend Yield
0.00%
P/E Ratio
-14.55
EPS
-26.71
Revenue
1.27M
Avg. Volume
731.90K
About
What does CDTX do?
Cidara Therapeutics, a San Diego-based biotechnology company with 69 employees, focuses on developing targeted immunotherapies for serious diseases, including oncology and antiviral treatments. Its lead candidate, CBO421, targets solid tumors, while CD388 addresses influenza prevention and treatment.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.